CervomedCRVO
13F holders, Q1 2024 (March 31)20holders
2famous investors
$23.30avg. 13F price*
At the end of Q1 2024, 20 institutions reported holding Cervomed Inc. (CRVO) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($20.1M), Armistice Capital, LLC ($17.1M) and Ikarian Capital, LLC ($5.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Cervomed Inc.
- CUSIP
- 15713L109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $50.2M |
| Exits | 1 | $6K |
Ownership 20 holders
| Ra Capital Management, L.P. | 0.26% | New | 861,573 | $20.1M |
| Armistice Capital, LLC | 0.46% | New | 734,363 | $17.1M |
| Ikarian Capital, LLC | 1.50% | New | 237,345 | $5.5M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | No change | 199,347 | $4.6M |
| Soleus Capital Management, L.P. | 0.26% | New | 126,614 | $3.0M |
| Crown Advisors Management, Inc. | 1.41% | New | 100,000 | $2.3M |
| Boothbay Fund Management, LLC | 0.05% | New | 69,014 | $1.6M |
| Cwm, LLC | 0.01% | Add +54.5% | 59,088 | $1.4M |
| Renaissance Technologies | 0.00% | Add +5.9% | 30,733 | $716K |
| Vanguard Group Inc. | 0.00% | Add +37.0% | 27,292 | $636K |
| BlackRock Inc. | 0.00% | Reduce -0.4% | 21,816 | $508K |
| Geode Capital Management, LLC | 0.00% | Add +34.8% | 21,175 | $494K |
| J. Goldman & Co LP | 0.01% | New | 13,500 | $315K |
| Point72 Asset Management | 0.00% | New | 10,000 | $233K |
| Hoey Investments, Inc. | 0.01% | No change | 1,080 | $25K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 990 | $23K |
| Osaic Holdings, Inc. | 0.00% | No change | 395 | $9K |
| Harbour Investments, Inc. | 0.00% | No change | 66 | $2K |
| Wells Fargo & Company | 0.00% | Add +7.1% | 15 | $350 |
| Morgan Stanley | 0.00% | No change | 2 | $47 |
"% of holder's portfolio" is CRVO's weight in each manager's 13F, not the share of Cervomed Inc. the manager owns.